| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/03/2002 | CN1343128A Medicinal compositions |
| 04/03/2002 | CN1343127A Potentiation of anti-CD38-immunotoxin cytotoxicity |
| 04/03/2002 | CN1343124A Bacterial membrane fractions with adjuvant effect |
| 04/03/2002 | CN1343122A Remedies for joint diseases |
| 04/03/2002 | CN1343119A Medicinal compositions retarded in discoloration of phenolic hydroxyl compounds |
| 04/03/2002 | CN1343118A Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 04/03/2002 | CN1343117A Method for improving stability of stored and/or used light-sensitive therapeutic systems or components thereof |
| 04/03/2002 | CN1343115A Skin sanitizing compositions |
| 04/03/2002 | CN1082043C Novel cationic lipids and the use thereof |
| 04/03/2002 | CN1082030C Fine Particles of petaloid porous hydroxyapatite and process for producing the same |
| 04/03/2002 | CN1081951C Use of ion exchange resins loader with quioolonecarboxylic acid derivatives |
| 04/03/2002 | CN1081919C Preparation for skin and mucous membrane |
| 04/02/2002 | US6365734 Cucurbituril derivatives, their preparation methods and uses |
| 04/02/2002 | US6365697 Water-soluble or water-dispersible polyurethanes with terminal acid groups, the production and the use thereof |
| 04/02/2002 | US6365664 Gels formed by the interaction of poly(aldehyde) with various substances |
| 04/02/2002 | US6365638 Process for preparation of hydrophilic or partially hydrophilic inorganic aerogels |
| 04/02/2002 | US6365637 Use of esters or amides of hydroxylated carboxylic acids as solubilizers |
| 04/02/2002 | US6365635 Topical applying; stability |
| 04/02/2002 | US6365596 Stability, shelf-life |
| 04/02/2002 | US6365583 Methods to enhance white blood cell count |
| 04/02/2002 | US6365364 Contacting plasminogen with kringle-4 protease to produce fragments of 50-70 kilodaltons, contacting fragments with elastase or plasmin to cleave ones containing first 50-80 amino acids of plasminogen, then isolating inhibitors |
| 04/02/2002 | US6365343 Treating rhinovirus infection by using insufflate for nasal administration composed of soluble interacellular adhesion molecule, type i; a bulking agent; and carboxymethyl cellulose, sodium salt |
| 04/02/2002 | US6365218 Xanthan gum hydrocolloid |
| 04/02/2002 | US6365207 Use of liquid carbohydrate fermentation product in foods |
| 04/02/2002 | US6365192 Bioactivating substance |
| 04/02/2002 | US6365190 Preparing aqueous solution of hydrophilic component and organic solution of hydrophobic component, delivering solutions to atomizer separately, atomizing together to produce droplets containing both components, spray drying |
| 04/02/2002 | US6365188 Solid mixtures of cyclodextrins prepared via meltextrusion |
| 04/02/2002 | US6365180 Oral liquid compositions |
| 04/02/2002 | US6365179 Conjugate having a cleavable linkage for use in a liposome |
| 04/02/2002 | US6365176 Nutritional supplement comprising low-glycemic index carbohydrate source, source of protein, source of fat, source of sterol and/or stanol, source of chromium, source of salicylic acid, and source of ginseng |
| 04/02/2002 | US6365175 Petroselinic acid and its use in food |
| 04/02/2002 | US6365166 Inducing interferon and tumor necrosis factor locally in the skin or mucous memebranes by applying 4-amino-2-ethoxymethyl-alpha,alpha-di methyl-1h-imidazo(4,5-c)quinoline-1-ethanol, silica sol, triacetin and propylene glycol |
| 04/02/2002 | US6365163 Immunological tolerance-inducing agent |
| 04/02/2002 | US6365148 Spray coating grains; sustained release |
| 04/02/2002 | US6364912 Pleiotrophin-based compositions for enhancing connective tissue repair |
| 04/02/2002 | CA2233277C Stable extract of hypericum perforatum l., processes for its preparation and pharmaceutical compositions |
| 04/02/2002 | CA2213700C Pharmaceutical composition for piperidinoalkanol compounds |
| 04/02/2002 | CA2056066C A physical form of n-[4-[5-(cyclopentyloxycarbony)amino-1-methylindol-3yl-methy1]-3-methoxybenzoy1]-2-methlbenzenesulphonamide, processes for its preparation and compositions containing it |
| 03/29/2002 | CA2357998A1 Composition to enhance permeation of topical skin agents |
| 03/28/2002 | WO2002025194A1 Drying method for selectively removing volatile components from wet coatings |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024832A1 Aggregate-forming agent |
| 03/28/2002 | WO2002024754A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 03/28/2002 | WO2002024751A1 Dextran-hemoglobin conjugates as blood substitutes |
| 03/28/2002 | WO2002024715A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 03/28/2002 | WO2002024623A2 Novel alkanoic acid derivatives |
| 03/28/2002 | WO2002024319A1 Microcapsule powder |
| 03/28/2002 | WO2002024232A2 Pei: dna vector formulations for in vitro and in vivo gene delivery |
| 03/28/2002 | WO2002024231A1 Use of a nucleic acid/pei complex |
| 03/28/2002 | WO2002024202A1 Nasal delivery of apomorphine in combination with glycol derivatives |
| 03/28/2002 | WO2002024193A1 Stabilised fibrate microparticles |
| 03/28/2002 | WO2002024192A1 Dipeptide ligands of the npff receptor for treating pain and hyperalgesia |
| 03/28/2002 | WO2002024185A2 Topical analgesic compositions containing aliphatic polyamines and methods of using same |
| 03/28/2002 | WO2002024180A2 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
| 03/28/2002 | WO2002024167A1 Medicinal composition |
| 03/28/2002 | WO2002024165A2 Preparation of vitamin emulsions and concentrates thereof |
| 03/28/2002 | WO2002024163A1 Solid dose nanoparticulate compositions |
| 03/28/2002 | WO2002024162A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment |
| 03/28/2002 | WO2002024158A2 Pulmonary delivery in treating disorders of the central nervous system |
| 03/28/2002 | WO2002024157A2 Acryl adhesive useful in transdermal drug delivery systems |
| 03/28/2002 | WO2002024154A2 Method for topical treatment of anthralin-responsive dermatological disorders |
| 03/28/2002 | WO2002024152A2 Oil in glycerin emulsion |
| 03/28/2002 | WO2002024150A2 Ultrasonic method and device for wound treatment |
| 03/28/2002 | WO2002024149A2 Immunogen comprising ligand bound hiv envelpe protein |
| 03/28/2002 | WO2002024143A2 Treating microbial infection of skin lesions |
| 03/28/2002 | WO2002024116A1 Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications |
| 03/28/2002 | WO2002023995A1 Method of blocking free radical processes which result in media ted pathology without deleterious pro-oxidant side reactions |
| 03/28/2002 | WO2002015882A8 Delayed release compositions and combinations |
| 03/28/2002 | WO2002011743A3 Treatment of prostate cancer |
| 03/28/2002 | WO2002002595A9 Amphipathic linear peptides and compositions containing same |
| 03/28/2002 | WO2002002056A3 Method of treatment of seborrheic dermatitis |
| 03/28/2002 | WO2001095857A3 Reusable extracorporeal colums loaded with ligand-dibiotin conjugates |
| 03/28/2002 | WO2001091725A3 Biologically useful polyphosphates |
| 03/28/2002 | WO2001090153A8 Reagents for cell selection and methods of use |
| 03/28/2002 | WO2001090144A3 Vip-related peptides for the treatment of sexual disorders in women |
| 03/28/2002 | WO2001089479A3 Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 03/28/2002 | WO2001083522A3 Growth factor modified protein matrices for tissue engineering |
| 03/28/2002 | WO2001080822A3 Effervescent granules and methods for their preparation |
| 03/28/2002 | WO2001078706A3 Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism |
| 03/28/2002 | WO2001076575A3 The treatment of respiratory diseases |
| 03/28/2002 | WO2001076370A3 Anthelmintic combinations |
| 03/28/2002 | WO2001072279A3 Medical emulsion for lubrication and delivery of drugs |
| 03/28/2002 | WO2001068038A3 System for the controlled delivery of an active material to a dental site |
| 03/28/2002 | WO2001051032A3 Micronized freeze-dried particles |
| 03/28/2002 | WO2001038552A3 Excipient system that contains coating substances with enzymatically removable side-groups |
| 03/28/2002 | WO2000048621A9 Methods and compositions for regulating protein-protein interactions |
| 03/28/2002 | US20020038032 Orally administrable acid stable antiulcer benzimidazole derivatives |
| 03/28/2002 | US20020038006 Human extracellular matrix proteins |
| 03/28/2002 | US20020037977 Polymer and plasticizing agent are capable of hydrogen or electrostatic bonding to each other and are present in a specific ratio |
| 03/28/2002 | US20020037949 Poly(ethylene glycol) derivatives with proximal reactive groups |
| 03/28/2002 | US20020037933 Sterile pharmaceutical for parenteral administration which comprises the compound 2,6-diisopropylphenol (propofol) with a sterile diluent or carrier; counteracting endotoxin induced deterioration of arterial oxygen tension |
| 03/28/2002 | US20020037919 Compositions and methods of paclitaxel for preventing psoriasis |
| 03/28/2002 | US20020037914 Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 03/28/2002 | US20020037898 Nutrient such as vitaminb 6 in the form of an ester, and a co-ester such as butyl benzoate which inhibits esterases; delivery to cells; bioavailability |
| 03/28/2002 | US20020037883 Topical mixture |
| 03/28/2002 | US20020037877 Pharmaceutical suspension compositions lacking a polymeric suspending agent |
| 03/28/2002 | US20020037863 Novel anthelmintic combinations |
| 03/28/2002 | US20020037841 Blood disorders; drug in aqueous solution |
| 03/28/2002 | US20020037839 Antiischemic agents; hypotensive agents; antiiflammatory agents |
| 03/28/2002 | US20020037833 Administering botulinium toxin component coupled to substance P |